The Prospect of Liver X Receptor(LXR) in Cardiovascular Disease

GU Wen-juan,LI Jiang

2010-01-01

Abstract:Nowadays Liver X Receptor(LXR) is a comparatively in-depth hot topic.LXR mainly involved in cholesterol metabolism ,fat formation,gluconeogenesis and inflammatory process.This text depicts in detail in the structure,function,clinical agonist of LXR as well as its role in clinical effects,additionally the research area in the future.

What problem does this paper attempt to address?

Liver X Receptors And Their Agonists: Targeting For Cholesterol Homeostasis And Cardiovascular Diseases

Zhiqiang Ma,Chao Deng,Wei Hu,Jie Zhou,Chongxi Fan,Shouyin Di,Dong Liu,Yang Yang,Dongjin Wang

DOI: https://doi.org/10.21775/cimb.022.041

2017-01-01

Current Issues in Molecular Biology

Abstract:Liver X receptors a (LXRa) and beta (LXR beta) are essential for protection against cardiovascular diseases. LXRs are members of the nuclear receptor superfamily of DNA-binding transcription factors and act as sensors of cholesterol homeostasis. In this review, we introduce LXRs and briefly describe the roles of LXRs in reverse cholesterol transport and trans-intestinal cholesterol efflux. We discuss LXR agonists and the downstream genes of LXRs that are involved in the regulation of cholesterol transport. In addition, we describe the cardioprotective effects of LXRs against atherosclerosis, myocardial ischemia/reperfusion injury, diabetic cardiomyopathy, and myocardial hypertrophy. Finally, we expand our discussion to the actions of LXRs in atherosclerosis and suggest several potential research avenues that may be of interest to clinicians and basic scientists. The information included herein may be useful for the design of future experimental research studies and may advance the investigation of LXRs as therapeutic targets.
Recent Advances on Liver X Receptors

Qiang Wang,Yu Jiang

2009-01-01

Abstract:The liver X receptors (LXRs), that are nuclear receptors activated by oxysterols, play central roles in the transcriptional control of cholesterol metabolism and function as the sensors of cholesterol homeostasis. In addition, LXRs have also been found to modulate lipogenesis, carbohydrate metabolism, innate immune and inflammatory responses in macrophages. Hence, the ability of LXRs to integrate metabolic and inflammatory signaling makes them particularly attractive targets for intervention in human atherosclerosis, hypercholesterolemia and type 2 diabetes.
Liver X receptors：the new orientation of drugs for metabolic diseases

Jingbo Zhang,Lei Zhao,Liang Yue,Haixiao Liu,Xia Li,Bodong Wang,Yan Qu

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2016.12.026

2016-01-01

Abstract:In mammals, the liver X receptor (LXR) is the key material in lipid balance. This type of transcription factor controls a series of genes' expression by organizational dependence, and these genes can regular cholesterol's uptake, transport, efflux and excretion. LXR belongs to the receptor ligands activate cells, as well as potential drug targets, through the manipulation of LXR pathways will help play a role of statins, and LXR ligand has been used for early clinical trials of atherosclerosis and hyperlipidemia. Meanwhile, new strategies for the pharmacological manipulation of LXR and their target genes offer promise for the treatment of human diseases in which lipids have a central role, including atherosclerosis and Alzheimer disease.
Liver X receptors as potential therapeutic targets for multiple diseases.

Guoqing Cao,Yu Liang,Xian-Cheng Jiang,Patrick I Eacho

DOI: https://doi.org/10.1358/dnp.2004.17.1.829024

2004-01-01

Drug News & Perspectives

Abstract:Liver X receptor alpha (LXRalpha) and liver X receptor beta(LXRbeta are oxysterol receptors that regulate multiple target genes involved in cholesterol homeostasis. Recent studies also suggest that the pair of receptors may also be involved in glucose metabolism, inflammation and Alzheimer's disease by regulating critical molecules involved in these pathophysiological processes. Although the prototypic LXR agonists induce liver triglyceride accumulation by regulating the hepatic lipogenesis pathway, it is hoped that a subtype-specific agonist or selective modulators would provide the desired cardioprotection and other benefits without the undesirable concomitant induction of lipogenesis. This review intends to summarize the most recent progress in the field and provide an assessment of LXRs as potential therapeutic targets.
Research progress on antiatherosclerosis mechanism of liver X receptors

Jing WEI,Jing-rui CHEN,Lin MIAO,Guan-wei FAN

DOI: https://doi.org/10.13699/j.cnki.1001-6821.2015.10.038

2015-01-01

Abstract:Liver X receptor is a ligand -activated transcription factor of nuclear receptor super family .It played a key role in the regulation of lipid metabolism.In the past decade , numerous studies show that liver X receptor are involved in a series of physiological processes such as meta-bolism and inflammation by activating or inhibiting its target genes that are so closely linked with cardiovascular diseases .In recent years, a large number of studies have shown that liver X receptor are increasingly prominent in fighting against atherosclerosis . In this paper , we will review the targets of the LXR pathways on the pathogenesis of atherosclerosis.
[Liver X Receptor: Crucial Mediator in Lipid and Carbohydrate Metabolism].

Yang Liu,Yong-sheng Chang,Fu-de Fang

2007-01-01

Abstract:Liver X receptors (LXRs) are members of the nuclear receptor superfamily and are activated by oxysterols and intermediates in the cholesterol synthetic pathway. The pivotal role of LXRs in the metabolic conversion of cholesterol to bile acids has been well established. Furthermore, insulin induces LXRa in hepatocytes, resulting in the suppression of key enzymes in gluconeogenesis, including phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and fructose-1, 6-bisphosphatase (FBPase). LXRs also play an important role in fatty acid metabolism by activating the sterol regulatory element-bing protein 1c gene (SREBP1c). This articles reviews the molecular mechanisms by which LXRs act to influence the lipid and carbohydrate metabolism.
Liver X Receptors As Potential Therapeutic Targets in Atherosclerosis

Yanfei Zhu,Yousheng Li

DOI: https://doi.org/10.25011/cim.v32i5.6927

2009-01-01

Abstract:Purpose: Atherosclerosis is the primary independent risk factor of cardiovascular disease, and Liver X Receptors (LXR? and LXR?) activation may play an anti-atherosclerosis effect. In this article, we summarize the current state of knowledge of roles of LXRs in physiology and homeostasis as well as the links between LXR action and atherosclerosis, and discuss the potential therapeutic effects of LXR agonists. Source: A MEDLINE database search was performed to identify relevant articles using the keywords “liver X receptors”, “LXRs”, and “atherosclerosis”. Additional papers were identified by a manual research of the references from the key articles. Principle findings: Both LXR isoforms promote reverse cholesterol transport (RCT) and have anti-inflammatory activity. LXR? is the predominant receptor in the liver regulating triglyceride synthesis. The antiatherosclerotic ability of LXRs makes them attractive targets for drugs for the treatment of cardiovascular disease. However, LXR activation induces lipogenesis and hypertriglyceridemia. The first-generation synthetic ligands of LXR increase hepatic lipogenesis and plasma triglyceride levels. New LXR ligands need to be designed without undesirable side effects. Conclusion: LXR ?-selective agonists and LXR modulators, which act as agonists in macrophages and induce cholesterol efflux while as antagonists of lipogenesis in the liver, are two critical and attractive approaches to treat atherosclerosis and cardiovascular diseases.
Recent Advance of LXR Affect on Cholesterol Homeostasis

YE Hang-yang,WANG Fei,LIU Xiao-hua,GUO Dong-mei,JIANG Yu

DOI: https://doi.org/10.13241/j.cnki.pmb.2013.18.021

2013-01-01

Abstract:Cholesterol is an important part of the cell membraneas,which is one of the basic molecular building blocks of life as well as the substrate for bile acid and steroid hormone synthesis,and it is regulated by many factors.Although cholesterol is required for normal cellular and physiological function,increased serum total cholesterol can lead to type 2 diabetes,high cholesterol,atherosclerosis and other diseases.Liver X receptor(LXR) is an important nuclear receptor,which is a ligand-dependent transcription factor and two LXR isotypes,LXRαand LXRβ,have been identified.LXRα is expressed in tissues with a high metabolic activity,including liver,adipose and macrophages,whereas LXRβ is ubiquitously expressed.LXRs regulate gene transcription by binding as heterodimers with retinoid X receptor.The activation of LXRs plays an important role in controlling cholesterol homeostasis by regulating the intestinal absorption of dietary cholesterol、liver cholesterol biosynthesis and uptake,Bile acid metabolism.In addition,LXR also involved in the regulation of adipogenesis,glucose metabolism,natural immune and inflammatory responses of macrophages and other physiological activities.Therefore,the ability of LXRs to integrate metabolic and inflammatory signaling makes them particularly attractive targets for intervention in human atherosclerosis and Alzheimer's disease.
Liver X receptors bridge hepatic lipid metabolism and inflammation.

Yuan Liu,De Kai Qiu,Xiong Ma

DOI: https://doi.org/10.1111/j.1751-2980.2011.00554.x

2012-01-01

Journal of Digestive Diseases

Abstract:Liver X receptors (LXRs) are members of the superfamily of metabolic nuclear receptors, which play central roles in the regulation of cholesterol absorption, efflux, transportation and excretion and many other processes correlating with lipid metabolism. LXRs can also regulate inflammation in vitro and in vivo. Accumulating evidence demonstrates that LXR are involved in the metabolism and inflammation in human diseases. Nonalcoholic fatty liver disease (NAFLD) is classically associated with lipid metabolic disorders and inflammatory responses, especially in the nonalcoholic steatohepatitis (NASH) phase. The effects of LXRs on cholesterol metabolism and inflammation make them attractive as a potential target for the treatment of NAFLD. Since the ability to synthesize triglycerides may be protective in obesity and fatty liver, the hepatic lipogenesis by LXRs should not rule out the possibility of the use of LXRs in NAFLD.
The Roles Of Liver X Receptor Alpha In Inflammation And Inflammation-Associated Diseases

Lin Zhao,Wangrui Lei,Chao Deng,Zhen Wu,Meng Sun,Zhenxiao Jin,Yanbin Song,Zhi Yang,Shuai Jiang,Mingzhi Shen,Yang Yang

DOI: https://doi.org/10.1002/jcp.30204

2021-01-01

Journal of Cellular Physiology

Abstract:Liver X receptor alpha (LXR alpha; also known as NR1H3), an isoform of LXRs, is a member of the nuclear receptor family of transcription factors and plays essential roles in the transcriptional control of cholesterol homeostasis. Previous in-depth phenotypic analyses of mouse models with deficient LXR alpha have also demonstrated various physiological functions of this receptor within inflammatory responses. LXR alpha activation exerts a combination of metabolic and anti-inflammatory actions resulting in the modulation and the amelioration of inflammatory disorders. The tight "repercussions" between LXR alpha and inflammation, as well as cholesterol homeostasis, have suggested that LXR alpha could be pharmacologically targeted in pathologies such as atherosclerosis, acute lung injury, and Alzheimer's disease. This review gives an overview of the recent advances in understanding the roles of LXR alpha in inflammation and inflammation-associated diseases, which will help in the design of future experimental researches on the potential of LXR alpha and advance the investigation of LXR alpha as pharmacological inflammatory targets.
Liver X receptor: a potential target in the treatment of atherosclerosis

Shreya R. Savla,Kedar S Prabhavalkar,Lokesh K Bhatt

DOI: https://doi.org/10.1080/14728222.2022.2117610

IF: 6.797

2022-09-07

Expert Opinion on Therapeutic Targets

Abstract:Liver X receptors (LXRs) are master regulators of atherogenesis. Their anti-atherogenic potential has been attributed to their role in the inhibition of macrophage-mediated inflammation and promotion of reverse cholesterol transport. Owing to the significance of their anti-atherogenic potential, it is essential to develop and test new-generation LXR agonists, both synthetic and natural, to identify potential LXR-targeted therapeutics for the future. This review describes the role of LXRs in atherosclerotic development, and provides a summary of LXR agonists and future directions for atherosclerosis research. We searched PubMed, Scopus, and Google Scholar for relevant reports, from last 10 years, using atherosclerosis, liver X receptor, and LXR agonist as keywords. LXRα has gained widespread recognition as a regulator of cholesterol homeostasis and expression of inflammatory genes. Further research using models of cell type‐specific knockout and specific agonist‐targeted LXR isoforms is warranted. Enthusiasm for therapeutic value of LXR agonists has been tempered due to LXRα-mediated induction of hepatic lipogenesis. LXRα agonism and LXRβ targeting, gut-specific inverse LXR agonists, investigations combining LXR agonists with other lipogenesis-mitigating agents, like IDOL antagonists and synthetic HDL, and targeting ABCA1, M2 macrophages, and LXRα phosphorylation remain as promising possibilities.

pharmacology & pharmacy
The multi-faceted role of retinoid X receptor in cardiovascular diseases

Mingyan Shao,Linghui Lu,Qian Wang,Lin Ma,Xue Tian,Changxiang Li,Chun Li,Dongqing Guo,Qiyan Wang,Wei Wang,Yong Wang

DOI: https://doi.org/10.1016/j.biopha.2021.111264

2021-05-01

Abstract:Retinoid X receptors (RXRs) are members of ligand-dependent transcription factors whose effects on a diversity of cellular processes, including cellular proliferation, the immune response, and lipid and glucose metabolism. Knock out of RXRα causes a hypoplasia of the myocardium which is lethal during fetal life. In addition, the heart maintains a well-orchestrated balances in utilizing fatty acids (FAs) and other substrates to meet the high energy requirements. As the master transcriptional regulators of lipid metabolism, RXRs become particularly important for the energy needs of the heart. Accumulating evidence suggested that RXRs may exert direct beneficial effects in the heart both through heterodimerization with other nuclear receptors (NRs) and homodimerization, thus standing as suitable targets for treating in cardiovascular diseases. Although compounds that target RXRs are promising drugs, their use is limited by toxicity. A better understanding of the structural biology of RXRs in cardiovascular disease should enable the rational design of more selective nuclear receptor modulators to overcome these problems. Here, this review summarizes a brief overview of RXRs structure and versatility of RXR action in the control of cardiovascular diseases. And we also discussed the therapeutic potential of RXR ligand.

pharmacology & pharmacy,medicine, research & experimental
The Emerging Role of Constitutive Androstane Receptor and Its Cross Talk with Liver X Receptors and Peroxisome Proliferator-Activated Receptor A in Lipid Metabolism.

Lei Xiao,Jing Wang,Mengxi Jiang,Wen Xie,Yonggong Zhai

DOI: https://doi.org/10.1016/b978-0-12-407766-9.00010-9

2013-01-01

Abstract:The regulation of lipid metabolism is central to energy homeostasis in higher multicellular organisms. Lipid homeostasis depends on factors that are able to transduce metabolic parameters into regulatory events representing the fundamental components of the general control system. Nuclear receptors form a superfamily of ligand-activated transcription factors implicated in various physiological functions including energy metabolism. The constitutive androstane receptor (CAR, NR1I3), initially identified as a xenobiotic-sensing receptor, may also have roles in lipid homeostasis. The nuclear receptors liver X receptors (LXRs, NR1H2/3) and peroxisome proliferator-activated receptors (PPARs, NR1C) have been known for their roles in lipid metabolism. LXR is a sterol sensor that promotes lipogenesis, whereas PPARα controls a variety of genes in several pathways of lipid metabolism. This chapter focuses primarily on the role of CAR in lipid metabolism directly or through its cross talk with LXRs and PPARα.
Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis

Antoine Jalil,Thibaut Bourgeois,Louise Ménégaut,Laurent Lagrost,Charles Thomas,David Masson

DOI: https://doi.org/10.3390/ijms20153787

IF: 5.6

2019-08-02

International Journal of Molecular Sciences

Abstract:Liver X receptors (LXRs) play a pivotal role in fatty acid (FA) metabolism. So far, the lipogenic consequences of in vivo LXR activation, as characterized by a major hepatic steatosis, has constituted a limitation to the clinical development of pharmacological LXR agonists. However, recent studies provided a different perspective. Beyond the quantitative accumulation of FA, it appears that LXRs induce qualitative changes in the FA profile and in the distribution of FAs among cellular lipid species. Thus, LXRs activate the production of polyunsaturated fatty acids (PUFAs) and their distribution into phospholipids via the control of FA desaturases, FA elongases, lysophosphatidylcholine acyltransferase (LPCAT3), and phospholipid transfer protein (PLTP). Therefore, LXRs control, in a dynamic manner, the PUFA composition and the physicochemical properties of cell membranes as well as the release of PUFA-derived lipid mediators. Recent studies suggest that modulation of PUFA and phospholipid metabolism by LXRs are involved in the control of lipogenesis and lipoprotein secretion by the liver. In myeloid cells, the interplay between LXR and PUFA metabolism affects the inflammatory response. Revisiting the complex role of LXRs in FA metabolism may open new opportunities for the development of LXR modulators in the field of cardiometabolic diseases.

biochemistry & molecular biology,chemistry, multidisciplinary
New Drug Targets LXR for Cholesterol Control

WANG Lu,LI Xue,WANG Xiao-Yan,LIU Xu-Dong

DOI: https://doi.org/10.3969/j.issn.1673-9523.2009.15.165

2009-01-01

Abstract:This brief review summarizes the discovery and development of nuclear receptor LXRs(Liver X Receptors) and their naturally occurring or synthetic ligands,with an emphasis on the pharmacological effects of some agonists,especially their therapeutic value on model animals as cholesterol metabolism regulators.It seems plausible for LXR selective modulators to be developed into clinical agents against vascular atherosclerosis and Alzheimer's disease.
Molecular mechanism of liver X receptors in cancer therapeutics

Qiang Wang,Jing Wang,Jiayou Wang,Heng Zhang

DOI: https://doi.org/10.1016/j.lfs.2021.119287

IF: 6.78

2021-05-01

Life Sciences

Abstract:Liver X receptors (LXRs) are receptors that belong to the nuclear receptor superfamily (NRs). It was originally called the "orphan receptor" when it was firstly discovered. Then it was found to be activated by oxysterol and it was officially named LXRs. LXRs are activated by ligands and bind to the retinol X receptor to form a heterodimer and regulate metabolism. Numerous studies have shown that LXRs are involved in regulating immune function and maintaining immune tolerance. Activating LXRs can also inhibit the tumorigenesis and promote apoptosis of tumor cells, which make LXRs as potential targets in cancer treatment. This review will discuss the recent progress of LXRs from the structure and function of LXRs, the signaling pathway of LXRs, the molecular mechanism of LXRs activation in cancers, and the potential targets of LXRs in cancer therapy.

pharmacology & pharmacy,medicine, research & experimental
Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis

Chu-Tian Mai,De-Chong Zheng,Xin-Zhi Li,Hua Zhou,Ying Xie,Xin-zhi Li

DOI: https://doi.org/10.1016/j.phrs.2021.105747

IF: 10.334

2021-08-01

Pharmacological Research

Abstract:Rheumatoid arthritis (RA) is a chronic multi-system autoimmune disease with extremely complex pathogenesis. Significantly altered lipid paradox related to the inflammatory burden is reported in RA patients, inducing 50% higher cardiovascular risks. Recent studies have also demonstrated that lipid metabolism can regulate many functions of immune cells in which metabolic pathways have altered. The nuclear liver X receptors (LXRs), including LXRα and LXRβ, play a central role in regulating lipid homeostasis and inflammatory responses. Undoubtedly, LXRs have been considered as an attractive therapeutic target for the treatment of RA. However, there are some contradictory effects of LXRs agonists observed in previous animal studies where both pro-inflammatory role and anti-inflammatory role were revealed for LXRs activation in RA. Therefore, in addition to updating the knowledge of LXRs as the prominent regulators of lipid homeostasis, the purpose of this review is to summarize the effects of LXRs agonists in RA-associated immune cells, to explore the underlying reasons for the contradictory therapeutic effects of LXRs agonists observed in RA animal models, and to discuss future strategy for the treatment of RA with LXRs modulators.

pharmacology & pharmacy
Advance in the research on several nuclear receptors related to bile acid metabolism

LI Xiao-Lin,ZHU Xin-Qiang

DOI: https://doi.org/10.3867/j.issn.1000-3002.2007.02.013

2007-01-01

Abstract:Bile acids are the major end-products of cholesterol metabolism and complex physiological molecules that are essential for solubilization, absorption, and transportation of dietary lipids in the liver and intestine. Many nuclear receptors coordinate transcription of bile acid homeostasis such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, liver X receptor, and peroxisome proliferator-activated receptor. Studies on nuclear receptors related to bile acid metabolism are important to know the regulation mechanism of bile acid metabolism and direct clinical drug usage.
Abstract 1453: LXR-623, a Novel Liver X Receptor Modulator, Displays Neutral Lipid Effects in Cholesteryl Ester Transfer Protein-expressing Species and Inhibits Atherosclerotic Lesion Progression in Low Density Lipoprotein Receptor Knockout Mice

Ponnal Nambi,Michael Basso,Liang Chen,Qiang-Yuan Liu,Anita R Halpern,Valérie Clerin,Christine Resmini,James C. Keith,Irene Feingold,Robert J. Steffan,Jay Wrobel,Elaine Quinet

IF: 37.8

2007-01-01

Circulation

Abstract:LXRα and LXRα are ligand-activated transcription factors involved in the upregulation of genes involved in reverse cholesterol transport (RCT), a process involved in cholesterol homeostasis. Unfort...
LXR agonists: new potential therapeutic drug for neurodegenerative diseases

Pei Xu,Dabing Li,Xiaotong Tang,Xiaohang Bao,Jing Huang,Yongping Tang,Yang Yang,Haiwei Xu,Xiaotang Fan

DOI: https://doi.org/10.1007/s12035-013-8461-3

Abstract:Liver X receptors (LXRs) are nuclear receptors involved in the regulation of lipid metabolism and inflammatory responses in the central nervous system. Defects in cholesterol homeostasis contribute to the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and Huntington's disease. Inflammatory responses could enhance the neurodegenerative process or act independently. The natural and synthetic LXR agonists induce the transcriptional activity of LXR target genes, thus attenuate the imbalance of cholesterol metabolism and overactivation of microglia and astrocytes in inflammation and are widely used in a variety of neurodegenerative diseases animal models. By developing more specific, potent, penetrable, and functional LXR agonist may lead to a better curative effect for neurodegenerative diseases and avoidance of potentially deleterious side effects. Here, we focus on recent advances in our understanding of the role of LXRs and their agonists in cholesterol homeostasis, inflammation, and the potential therapeutic effects in neurodegenerative diseases.

The Prospect of Liver X Receptor(LXR) in Cardiovascular Disease

Liver X Receptors And Their Agonists: Targeting For Cholesterol Homeostasis And Cardiovascular Diseases

Recent Advances on Liver X Receptors

Liver X receptors：the new orientation of drugs for metabolic diseases

Liver X receptors as potential therapeutic targets for multiple diseases.

Research progress on antiatherosclerosis mechanism of liver X receptors

[Liver X Receptor: Crucial Mediator in Lipid and Carbohydrate Metabolism].

Liver X Receptors As Potential Therapeutic Targets in Atherosclerosis

Recent Advance of LXR Affect on Cholesterol Homeostasis

Liver X receptors bridge hepatic lipid metabolism and inflammation.

The Roles Of Liver X Receptor Alpha In Inflammation And Inflammation-Associated Diseases

Liver X receptor: a potential target in the treatment of atherosclerosis

The multi-faceted role of retinoid X receptor in cardiovascular diseases

The Emerging Role of Constitutive Androstane Receptor and Its Cross Talk with Liver X Receptors and Peroxisome Proliferator-Activated Receptor A in Lipid Metabolism.

Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis

New Drug Targets LXR for Cholesterol Control

Molecular mechanism of liver X receptors in cancer therapeutics

Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis

Advance in the research on several nuclear receptors related to bile acid metabolism

Abstract 1453: LXR-623, a Novel Liver X Receptor Modulator, Displays Neutral Lipid Effects in Cholesteryl Ester Transfer Protein-expressing Species and Inhibits Atherosclerotic Lesion Progression in Low Density Lipoprotein Receptor Knockout Mice

LXR agonists: new potential therapeutic drug for neurodegenerative diseases